Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

NCT03490942 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

49

Enrollment

INDUSTRY

Sponsor class

Stopped Primary endpoint was not met

Conditions

Hypoglycemia Unawareness
Diabetes Mellitus, Type 1

Interventions

DRUG: Glucagon
DRUG: Placebo

Sponsor

Xeris Pharmaceuticals

Collaborators

[object Object]